Are you Dr. Albain?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2160 S 1st Ave
"# 101-1740"
Maywood, IL 60153Phone+1 708-216-9000Fax+1 708-216-9033
Summary
- Dr. Kathy Albain, MD is an oncologist in Maywood, Illinois. She is currently licensed to practice medicine in Illinois. She is a Professor of Medical Oncology at Loyola University-Stritch School of Medicine.
Education & Training
- University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
- IL State Medical License 1979 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsDevelopment and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.Lajos Pusztai, Jess R Hoag, Kathy S Albain, William E Barlow, Salomon M Stemmer
Journal of Clinical Oncology. 2025-03-10 - Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial.Yara Abdou, William E Barlow, Julie R Gralow, Funda Meric-Bernstam, Kathy S Albain
Journal of the National Cancer Institute. 2024-12-05 - 2 citationsDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda
Nature Medicine. 2024-12-01
Press Mentions
- RSClin Tool N+ Enhances Breast Cancer Risk EstimatesJanuary 23rd, 2025
- Loyola University Chicago’s Kathy Albain, MD to Receive Prestigious National Award for Pioneering Breast Cancer ResearchJune 3rd, 2022
- Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer DoctorsNovember 6th, 2019
- Join now to see all